1. Home
  2. MDXG vs JFR Comparison

MDXG vs JFR Comparison

Compare MDXG & JFR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MDXG
  • JFR
  • Stock Information
  • Founded
  • MDXG 2006
  • JFR 2004
  • Country
  • MDXG United States
  • JFR United States
  • Employees
  • MDXG N/A
  • JFR N/A
  • Industry
  • MDXG Biotechnology: Pharmaceutical Preparations
  • JFR Trusts Except Educational Religious and Charitable
  • Sector
  • MDXG Health Care
  • JFR Finance
  • Exchange
  • MDXG Nasdaq
  • JFR Nasdaq
  • Market Cap
  • MDXG 1.3B
  • JFR 1.2B
  • IPO Year
  • MDXG N/A
  • JFR N/A
  • Fundamental
  • Price
  • MDXG $8.79
  • JFR $8.57
  • Analyst Decision
  • MDXG Strong Buy
  • JFR
  • Analyst Count
  • MDXG 5
  • JFR 0
  • Target Price
  • MDXG $12.00
  • JFR N/A
  • AVG Volume (30 Days)
  • MDXG 586.8K
  • JFR 621.7K
  • Earning Date
  • MDXG 02-26-2025
  • JFR 01-01-0001
  • Dividend Yield
  • MDXG N/A
  • JFR 11.31%
  • EPS Growth
  • MDXG N/A
  • JFR N/A
  • EPS
  • MDXG 0.52
  • JFR N/A
  • Revenue
  • MDXG $342,804,000.00
  • JFR N/A
  • Revenue This Year
  • MDXG $9.56
  • JFR N/A
  • Revenue Next Year
  • MDXG $9.19
  • JFR N/A
  • P/E Ratio
  • MDXG $17.04
  • JFR N/A
  • Revenue Growth
  • MDXG 10.93
  • JFR N/A
  • 52 Week Low
  • MDXG $5.47
  • JFR $7.61
  • 52 Week High
  • MDXG $10.14
  • JFR $8.82
  • Technical
  • Relative Strength Index (RSI)
  • MDXG 44.77
  • JFR 33.59
  • Support Level
  • MDXG $8.50
  • JFR $8.39
  • Resistance Level
  • MDXG $9.36
  • JFR $8.59
  • Average True Range (ATR)
  • MDXG 0.27
  • JFR 0.09
  • MACD
  • MDXG -0.02
  • JFR -0.03
  • Stochastic Oscillator
  • MDXG 33.72
  • JFR 26.09

About MDXG MiMedx Group Inc

MiMedx Group Inc develops and markets regenerative biomaterial products and bioimplants made from the human amniotic membrane, birth tissues, and human skin & bone. Its products are primarily targeted towards the wound-care, burn, surgical, sports medicine, and orthopedics markets. MiMedx's key products are allografts processed from amniotic tissue, which include EpiFix for external use and AmnioFix for internal use. AmnioCord, AmnioFill, EpiBurn, and EpiCord are some of its other products. Also, it sells allografts for ophthalmic surgery and dental applications through licenses to third parties.

About JFR Nuveen Floating Rate Income Fund

Nuveen Floating Rate Income Fund is a diversified closed-end management investment company. Its investment objective is to achieve a high level of current income, consistent with the preservation of capital. It invests in adjustable-rate U.S. dollar-denominated secured Senior Loans.

Share on Social Networks: